Welcoming a New Member to the Florida Cancer Specialists' Team
Florida Cancer Specialists & Research Institute (FCS) has proudly added board-certified medical oncologist and hematologist Dr. Sunil Rohatgi to its exceptional team dedicated to fighting cancer. With his extensive training and commitment to patient care, Dr. Rohatgi is set to make a positive impact in Citrus County, where he begins seeing patients.
Dr. Rohatgi's Professional Background
Dr. Rohatgi earned his medical degree from the University of Florida College of Medicine. He completed his internal medicine residency at Baylor College of Medicine and pursued a fellowship in oncology and hematology at New York University College of Medicine. This thorough education has equipped him with the skills necessary to provide exceptional care to his patients.
Commitment to Patient-Centered Care
At the heart of Dr. Rohatgi's approach is a commitment to patient-centered care. He believes in the importance of understanding each patient's unique journey and aims to offer both innovative treatments and compassionate support through their struggles. His dedication to this philosophy resonates with the mission of FCS, which values meaningful interactions with patients.
Remarks from the FCS Leadership
David Wenk, MD, Assistant Managing Physician at FCS, expressed enthusiasm about Dr. Rohatgi's arrival. He stated, "Dr. Rohatgi is a talented physician who has undergone rigorous training at some of the nation's leading medical institutions. His expertise in advanced precision oncology therapies will enhance our team greatly."
Nathan H. Walcker, the Chief Executive Officer of FCS, echoed these sentiments. He remarked, "Welcoming Dr. Rohatgi adds significant strength to our cancer care team in Citrus County. His dedication to patient support and cutting-edge treatment aligns perfectly with our goals and mission.”
Locations Offering Care
Dr. Rohatgi will be available at two FCS locations: Lecanto and Inverness. At the Lecanto site, he will provide services at 521 N Lecanto Hwy., while in Inverness, he will be accessible at 2231 Highway 44 W., Ste. 203. Both facilities are equipped with the latest technologies and resources needed to facilitate high-quality cancer treatment.
About Florida Cancer Specialists & Research Institute
For over four decades, Florida Cancer Specialists & Research Institute has been at the forefront of innovation in oncology. The organization prides itself on delivering world-class cancer care and transforming the landscape of oncology treatment through a robust clinical research program.
FCS not only provides extensive access to clinical trials but also leads among private oncology practices in Florida and beyond. Notably, many of the newest cancer drugs approved by the FDA were first introduced to patients through clinical trials at FCS. This pivotal role highlights FCS's commitment to advancing cancer care and improving patient outcomes.
The highly trained and dedicated team at FCS strives to develop tailored treatment plans that leverage cutting-edge advancements in precision oncology, ensuring that each patient receives the best possible care.
Frequently Asked Questions
What does Dr. Sunil Rohatgi bring to Florida Cancer Specialists?
Dr. Rohatgi brings his expertise as a trained medical oncologist and hematologist, enhancing patient care with innovative treatments.
Where will Dr. Rohatgi be seeing patients?
He will be providing care at the FCS locations in Lecanto and Inverness.
What is the mission of Florida Cancer Specialists?
FCS aims to deliver world-class cancer care and innovative treatments through an extensive clinical research program.
How long has Florida Cancer Specialists been operating?
FCS has been a pioneer in cancer care for over 40 years.
Why are clinical trials important at FCS?
Clinical trials at FCS provide patients with early access to new therapies that could improve outcomes and contribute to innovative cancer treatment options.
